COVID-19 Response

AEI clients in the COVID-19 fight: Houston Methodist

First US experimental plasma treatment against COVID-19 now being tested at Houston Methodist.

Developed by the physician-scientists at Houston Methodist, a convalescent serum therapy against the COVID-19 virus is currently undergoing testing there as potentially lifesaving treatment for infected patients. While vaccines and antiviral drugs can take months and even years to develop, this treatment – transfusing vital antibodies found in the plasmas of recovered COVID-19 patients into critically ill patients – has Food and Drug Administration classification as an emergency investigational new drug protocol for immediate use, as individually approved by the FDA.

Click to read full article

Post Date